搜索医生

David J. Sas, D.O.

  1. Pediatric Nephrologist
  2. Pediatrician
预约门诊

出版物

  1. Michael M, Harvey E, Milliner DS, Frishberg Y, Sas DJ, Calle J, Copelovitch L, Penniston KL, Saland J, Somers MJG, Baum MA. Diagnosis and management of primary hyperoxalurias: best practices. Pediatr Nephrol. 2024 Nov; 39 (11):3143-3155 Epub 2024 May 16
    View PubMed
  2. Cellini B, Baum MA, Frishberg Y, Groothoff JW, Harris PC, Hulton SA, Knauf F, Knight J, Lieske JC, Lowther WT, Moochhala S, Nazzal L, Tasian GE, Whittamore JM, Sas DJ. Opportunities in Primary and Enteric Hyperoxaluria at the Cross-Roads Between the Clinic and Laboratory. Kidney Int Rep. 2024 Nov; 9 (11):3083-3096 Epub 2024 Sept 01
    View PubMed
  3. Habash NW, Jaoudeh RARA, Hentz RC, Sas DJ, Ibrahim SH, Hassan S. Primary hyperoxaluria: Long-term outcomes of isolated kidney versus simultaneous liver/kidney transplant. J Pediatr Gastroenterol Nutr. 2024 Oct; 79 (4):826-834 Epub 2024 July 15
    View PubMed
  4. Sas DJ, Mara K, Mehta RA, Seide BM, Banks CJ, Danese DS, McGregor TL, Lieske JC, Milliner DS. Natural history of urine and plasma oxalate in children with primary hyperoxaluria type 1. Pediatr Nephrol. 2024 Jan; 39 (1):141-148 Epub 2023 July 17
    View PubMed
  5. Frishberg Y, Hayes W, Shasha-Lavsky H, Sas DJ, Michael M, Sellier-Leclerc AL, Hogan J, Willey R, Gansner JM, Magen D. Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial. Front Pediatr. 2024; 12:1392644 Epub 2024 Sept 16
    View PubMed
  6. Ungerer GN, Liaw CW, Potretzke AM, Sas DJ, Gargollo PC, Granberg CF, Koo K. Examination of nutritional factors associated with urolithiasis risk in plant based meat alternatives marketed to children and infants. J Pediatr Urol. 2023 Oct; 19 (5):513.e1-513.e7 Epub 2023 Apr 17
    View PubMed
  7. Sas DJ, Absah I, Phelan SM, Joshi AY, Creo AL, Behl S, Hanson KT, Kumar S. Patient Satisfaction Scores Impact Pediatrician Practice Patterns, Job Satisfaction, and Burnout. Clin Pediatr (Phila). 2023 Jul; 62 (7):769-780 Epub 2022 Dec 22
    View PubMed
  8. Genena KM, Sas DJ, Milliner DS, Lieske JC. Successful Treatment of Primary Hyperoxaluria Type 2 with a Combined Liver and Kidney Transplant. Kidney Int Rep. 2023 Jul; 8 (7):1469-1472 Epub 2023 Mar 23
    View PubMed
  9. Arnous MG, Arroyo J, Cogal AG, Anglani F, Kang HG, Sas D, Harris PC, Lieske JC. The Site and Type of CLCN5 Genetic Variation Impact the Resulting Dent Disease-1 Phenotype. Kidney Int Rep. 2023 Jun; 8 (6):1220-1230 Epub 2023 Mar 23
    View PubMed
  10. Hayes W, Sas DJ, Magen D, Shasha-Lavsky H, Michael M, Sellier-Leclerc AL, Hogan J, Ngo T, Sweetser MT, Gansner JM, McGregor TL, Frishberg Y. Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial. Pediatr Nephrol. 2023 Apr; 38 (4):1075-1086 Epub 2022 Aug 01
    View PubMed
  11. Singh P, Vaughan LE, Schulte PJ, Sas DJ, Milliner DS, Lieske JC. Estimated GFR Slope Across CKD Stages in Primary Hyperoxaluria Type 1. Am J Kidney Dis. 2022 Sep; 80 (3):373-382 Epub 2022 Mar 16
    View PubMed
  12. Schlaht KM, Sas DJ, Davis DMR, Hand JL. An investigation of metabolic disturbances, including urinary stone disease, hypothyroidism, and osteoporosis in basal cell nevus syndrome. Pediatr Dermatol. 2022 Sep; 39 (5):713-717 Epub 2022 May 16
    View PubMed
  13. Singh P, Viehman JK, Mehta RA, Cogal AG, Hasadsri L, Oglesbee D, Olson JB, Seide BM, Sas DJ, Harris PC, Lieske JC, Milliner DS. Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2. Nephrol Dial Transplant. 2022 Apr 25; 37 (5):869-875
    View PubMed
  14. Singh P, Harris PC, Sas DJ, Lieske JC. The genetics of kidney stone disease and nephrocalcinosis. Nat Rev Nephrol. 2022 Apr; 18 (4):224-240 Epub 2021 Dec 14
    View PubMed
  15. Sas DJ, Magen D, Hayes W, Shasha-Lavsky H, Michael M, Schulte I, Sellier-Leclerc AL, Lu J, Seddighzadeh A, Habtemariam B, McGregor TL, Fujita KP, Frishberg Y, ILLUMINATE-B Workgroup. Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children. Genet Med. 2022 Mar; 24 (3):654-662 Epub 2021 Dec 08
    View PubMed
  16. Hanna C, Potretzke TA, Chedid M, Rangel LJ, Arroyo J, Zubidat D, Tebben PJ, Cogal AG, Torres VE, Harris PC, Sas DJ, Lieske JC, Milliner DS, Chebib FT. Kidney Cysts in Hypophosphatemic Rickets With Hypercalciuria: A Case Series. Kidney Med. 2022 Mar; 4 (3):100419 Epub 2022 Jan 24
    View PubMed
  17. Hulton SA, Groothoff JW, Frishberg Y, Koren MJ, Overcash JS, Sellier-Leclerc AL, Shasha-Lavsky H, Saland JM, Hayes W, Magen D, Moochhala SH, Coenen M, Simkova E, Garrelfs SF, Sas DJ, Meliambro KA, Ngo T, Sweetser MT, Habtemariam BA, Gansner JM, McGregor TL, Lieske JC. Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1. Kidney Int Rep. 2022 Mar; 7 (3):494-506 Epub 2021 Dec 11
    View PubMed
  18. Niaz T, Stephens EH, Gleich SJ, Dearani JA, Johnson JN, Sas DJ, Bly S, Driscoll DJ, Cetta F. Acute Kidney Injury and Renal Replacement Therapy After Fontan Operation. Am J Cardiol. 2021 Dec 15; 161:84-94
    View PubMed
  19. Heidenreich LS, Thacker PG, Chebib FT, Sas DJ, Hanna C. An infant with hyperechoic cystic kidneys and congenital diaphragmatic hernia: Questions. Pediatr Nephrol. 2021 Dec; 36 (12):4083-4084 Epub 2021 Aug 05
    View PubMed
  20. Heidenreich LS, Thacker PG, Chebib FT, Sas DJ, Hanna C. An infant with hyperechoic cystic kidneys and congenital diaphragmatic hernia: Answers. Pediatr Nephrol. 2021 Dec; 36 (12):4085-4087 Epub 2021 Aug 05
    View PubMed
  21. Cogal AG, Arroyo J, Shah RJ, Reese KJ, Walton BN, Reynolds LM, Kennedy GN, Seide BM, Senum SR, Baum M, Erickson SB, Jagadeesh S, Soliman NA, Goldfarb DS, Beara-Lasic L, Edvardsson VO, Palsson R, Milliner DS, Sas DJ, Lieske JC, Harris PC, Investigators of the Rare Kidney Stone Consortium. Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease. Kidney Int Rep. 2021 Nov; 6 (11):2862-2884 Epub 2021 Sept 08
    View PubMed
  22. Azer SM, Vaughan LE, Tebben PJ, Sas DJ. 24-Hydroxylase Deficiency Due to CYP24A1 Sequence Variants: Comparison With Other Vitamin D-mediated Hypercalcemia Disorders. J Endocr Soc. 2021 Sep 1; 5 (9):bvab119 Epub 2021 July 02
    View PubMed
  23. Hanna C, Potretzke TA, Cogal AG, Mkhaimer YG, Tebben PJ, Torres VE, Lieske JC, Harris PC, Sas DJ, Milliner DS, Chebib FT. High Prevalence of Kidney Cysts in Patients With CYP24A1 Deficiency. Kidney Int Rep. 2021 Jul; 6 (7):1895-1903 Epub 2021 May 12
    View PubMed
  24. Wilbanks J, Hillyer J, Hashim F, Sas D, Hanna C. A toddler with severe hypercalcemia and pyelonephritis: Questions. Pediatr Nephrol. 2021 Apr; 36 (4):857-858 Epub 2020 July 20
    View PubMed
  25. Wilbanks J, Hillyer J, Hashim F, Sas D, Hanna C. A toddler with severe hypercalcemia and pyelonephritis: Answers. Pediatr Nephrol. 2021 Apr; 36 (4):859-861 Epub 2020 July 20
    View PubMed
  26. Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O'Riordan WD, Cochat P, Deschenes G, Shasha-Lavsky H, Saland JM, Van't Hoff WG, Fuster DG, Magen D, Moochhala SH, Schalk G, Simkova E, Groothoff JW, Sas DJ, Meliambro KA, Lu J, Sweetser MT, Garg PP, Vaishnaw AK, Gansner JM, McGregor TL, Lieske JC, ILLUMINATE-A Collaborators. Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1. N Engl J Med. 2021 Apr 1; 384 (13):1216-1226
    View PubMed
  27. Christensen S, Tebben PJ, Sas D, Creo AL. Variable Clinical Presentation of Children with Hereditary Hypophosphatemic Rickets with Hypercalciuria: A Case Series and Review of the Literature. Horm Res Paediatr 2021; 94 (9-10):374-389 Epub 2021 Oct 19
    View PubMed
  28. Pinto E Vairo F, Prochnow C, Kemppainen JL, Lisi EC, Steyermark JM, Kruisselbrink TM, Pichurin PN, Dhamija R, Hager MM, Albadri S, Cornell LD, Lazaridis KN, Klee EW, Senum SR, El Ters M, Amer H, Baudhuin LM, Moyer AM, Keddis MT, Zand L, Sas DJ, Erickson SB, Fervenza FC, Lieske JC, Harris PC, Hogan MC. Genomics Integration Into Nephrology Practice. Kidney Med. 2021 Sep-Oct; 3(5):785-798. Epub 2021 Jun 29.
    View PubMed
  29. Sas DJ, Enders FT, Gunderson TM, Mehta RA, Olson JB, Seide BM, Banks CJ, Dehmel B, Pellikka PA, Lieske JC, Milliner DS. Natural History of Clinical, Laboratory, and Echocardiographic Parameters of a Primary Hyperoxaluria Cohort on Long Term Hemodialysis. Front Med (Lausanne). 2021; 8:592357 Epub 2021 Apr 09
    View PubMed
  30. Warring SK, Novoa V, Shazly S, Trinidad MC, Sas DJ, Schiltz B, Prieto M, Terzic A, Ruano R. Serial Amnioinfusion as Regenerative Therapy for Pulmonary Hypoplasia in Fetuses With Intrauterine Renal Failure or Severe Renal Anomalies: Systematic Review and Future Perspectives. Mayo Clin Proc Innov Qual Outcomes. 2020 Aug; 4 (4):391-409 Epub 2020 Aug 05
    View PubMed
  31. Sas DJ. Dietary risk factors for urinary stones in children. Curr Opin Pediatr. 2020 Apr; 32 (2):284-287
    View PubMed
  32. Sas DJ, Enders FT, Mehta RA, Tang X, Zhao F, Seide BM, Milliner DS, Lieske JC. Clinical features of genetically confirmed patients with primary hyperoxaluria identified by clinical indication versus familial screening. Kidney Int. 2020 Apr; 97 (4):786-792 Epub 2019 Dec 13
    View PubMed
  33. Sas DJ, Harris PC, Milliner DS. Recent advances in the identification and management of inherited hyperoxalurias. Urolithiasis. 2019 Feb; 47 (1):79-89 Epub 2018 Dec 10
    View PubMed
  34. Sas DJ, Becton LJ, Tutman J, Lindsay LA, Wahlquist AH. Clinical, demographic, and laboratory characteristics of children with nephrolithiasis. Urolithiasis. 2016 Jun; 44 (3):241-6 Epub 2015 Oct 14
    View PubMed
  35. Tran CL, Sethi S, Murray D, Cramer CH, Sas DJ, Willrich M, Smith RJ, Fervenza FC. Discontinuation of dialysis with eculizumab therapy in a pediatric patient with dense deposit disease. Pediatr Nephrol. 2016 Apr; 31 (4):683-7 Epub 2016 Jan 13
    View PubMed
  36. Tasian GE, Ross ME, Song L, Sas DJ, Keren R, Denburg MR, Chu DI, Copelovitch L, Saigal CS, Furth SL. Annual Incidence of Nephrolithiasis among Children and Adults in South Carolina from 1997 to 2012. Clin J Am Soc Nephrol. 2016 Mar 7; 11 (3):488-96 Epub 2016 Jan 14
    View PubMed
  37. Shatat IF, Taber DJ, Shrivastava S, Weimert NA, Sas DJ, Chavin KD, Orak JK, Baliga PK. Graft outcomes in pediatric kidney transplantation: focus on the role of race. Saudi J Kidney Dis Transpl. 2012 Jul; 23(4):684-92.
    View PubMed
  38. Shatat IF, Abdallah RT, Sas DJ, Hailpern SM. Serum uric acid in U.S. adolescents: distribution and relationship to demographic characteristics and cardiovascular risk factors. Pediatr Res. 2012 Mar 30.
    View PubMed
  39. Sas DJ. An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease. Clin J Am Soc Nephrol. 2011 Aug; 6(8):2062-8. Epub 2011 Jul 07.
    View PubMed
  40. Horner KB, Sas DJ. White urine in an asymptomatic child. J Pediatr. 2011 Aug; 159(2):351. Epub 2011 May 17.
    View PubMed
  41. Sas DJ, Hulsey TC, Shatat IF, Orak JK. Increasing incidence of kidney stones in children evaluated in the emergency department. J Pediatr. 2010 Jul; 157(1):132-7. Epub 2010 Apr 1
    View PubMed
  42. Sas D, Hu M, Moe OW, Baum M. Effect of claudins 6 and 9 on paracellular permeability in MDCK II cells. Am J Physiol Regul Integr Comp Physiol. 2008 Nov; 295(5):R1713-9. Epub 2008 Sep 10.
    View PubMed
  43. Gattineni J, Sas D, Dagan A, Dwarakanath V, Baum M. Effect of thyroid hormone on the postnatal renal expression of NHE8. Am J Physiol Renal Physiol. 2008 Jan; 294(1):F198-204. Epub 2007 Oct 31
    View PubMed
  44. Sas D, Enrione MA, Schwartz RH. Pseudomonas aeruginosa septic shock secondary to "gripe water" ingestion. Pediatr Infect Dis J. 2004 Feb; 23(2):176-7.
    View PubMed
PST-20217339